Clinical Trial Update: Tocilizumab in Children With ACP [EARLY_Phase 1]

View source ↗

Summary

EARLY_PHASE1 trial update describing Tocilizumab in pediatric Adamantinomatous craniopharyngioma; the study is active but not currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adamantinomatous Craniopharyngioma

Drugs mentioned

• Tocilizumab (tocilizumab)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Adamantinomatous Craniopharyngioma | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING